Catalent Pharma Solutions, a US-based provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, has acquired Australian pharmaceutical packaging business, Pharmapak Technologies, ...
Tags: delivery technologies, Pacific, Packaging
The UK National Institute for Health and Care Excellence (Nice) has approved the use of nalmefene to help people cut down on alcohol consumption. Also called Selincro, Nalmefene is recommended for men who drink more than 7.5 units a ...
Tags: alcohol, nalmefene, Agriculture
Afrezza hopes that its inhalable insulin product will be a gamechanger for diabetics. (Image courtesy Afrezza). Insulin injections may soon be a thing of the past if Mannkind Corp.'s inhalable insulin product, Afrezza, is approved by ...
Scientists at The Scripps Research Institute (TSRI) have developed a method for modifying organic molecules that significantly expands the possibilities for developing new pharmaceuticals and improving old ones. "This is a technology that ...
Cross section of bioprinted human liver tissue showing hepatocytes (blue nuclei), endothelial cells (red), and hepatic stellate cells (green). (Courtesy Organovo Holdings Inc.) The discovery that living tissues could be built up using a ...
Tags: Organovo, 3-D printer
In research that could ultimately lead to many new medicines, scientists from the Florida campus of The Scripps Research Institute (TSRI) have developed a potentially general approach to design drugs from genome sequence. As a proof of ...
Tags: Identify New Drug Candidates, unparalleled selectivity, cell permeable
SAN FRANCISCO, Feb. 25 (UPI) -- Researchers have found that the cannabis chemical CBD reportedly helps children with epilepsy have fewer seizures. The form of cannabis, "Charlotte's web," is bred without the psychoactive chemical THC and ...
Tags: Cannabis Chemical, Epilepsy, Medicine
US-based biotechnology firm Vertex Pharmaceuticals has received approval from the US Food and Drug Administration (FDA) for a supplemental New Drug Application (sNDA) of its Kalydeco (ivacaftor) for the treatment of people with cystic ...
Tags: FDA Approval, Vertex, Kalydeco sNDA
Article cites potential to save money on end-of-life care, medical imaging and new drug prices In a review article published Feb. 14 in The Lancet Oncology, Johns Hopkins experts identify three major sources of high cancer costs and argue ...
DTect-All(TM) platform will be used to screen for GPCR-directed allosteric modulator antibodies Domain Therapeutics, a biopharmaceutical company specializing in the research and development of new drug candidates targeting G ...
Tags: DTect-All(TM)
TUESDAY Feb. 4, 2014, 2014 -- In a first-of-its-kind initiative, the U.S. National Institutes of Health has partnered with 10 drug companies and several nonprofit groups to speed development of biological ways of diagnosing and treating ...
Hetlioz (tasimelteon) has been approved by the U.S. Food and Drug Administration to treat a sleep condition caused by a completely blind person's inability to regulate the body clock by recognizing light from dark. The condition is ...
Tags: blind person's inability, new drug
US-based Medac Pharma has reported the US Food and Drug Administration (FDA) acceptance of a new drug application (NDA) for its lead product candidate, MPI-2505, a subcutaneous injectable methotrexate (MTX) in a ready-to-use injection ...
Teva Pharmaceuticals has received approval from the US Food and Drug Administration (FDA) for its supplemental new drug application (sNDA) for three-times-a-week COPAXONE 40mg/mL, a new dose of COPAXONE. COPAXONE (glatiramer acetate ...
Hi-Tech Pharmacal Co., Inc. (NASDAQ:HITK), a specialty pharmaceuticals company, announced today that the US Food and Drug Administration, (FDA) granted final approval for the Company's Abbreviated New Drug Application, (ANDA) for Bromfenac ...